ASCO® GU 2024 Insights: "Rate of Hospitalization and Length of Hospital Stay During and Post Docetaxel for Darolutamide in mHSPC Using ARASENS"
By
Dana-Farber Cancer Institute
FEATURING
Alicia Morgans
By
Dana-Farber Cancer Institute
FEATURING
Alicia Morgans
Login to view comments.
Click here to Login